Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
This study has been completed.
Study NCT00402584   Information provided by Abbott
First Received: November 20, 2006   Last Updated: August 30, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Binge Eating Disorder
Obesity
Additional conditions recognized in this trial
Bulimia
Bulimia Nervosa
Disease
Eating Disorders
More general conditions related to this trial
Body Weight
Hyperphagia
Mental Disorders
Nutrition Disorders
Overnutrition
Overweight
Pathologic Processes
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
sibutramine
More general drug interventions related to this trial
Anti-Obesity Agents
Antidepressive Agents
Appetite Depressants
Central Nervous System Agents
Pharmacologic Actions
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
Abbott


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services